Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies
- 1 May 2009
- journal article
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 67 (5) , 35-43
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008
- Mandible Matrix Necrosis in Beagle Dogs After 3 Years of Daily Oral Bisphosphonate TreatmentJournal of Oral and Maxillofacial Surgery, 2008
- Inhibition of Oral Mucosal Cell Wound Healing by BisphosphonatesJournal of Oral and Maxillofacial Surgery, 2008
- Zoledronate, Smoking, and Obesity Are Strong Risk Factors for Osteonecrosis of the Jaw: A Case-Control StudyJournal of Oral and Maxillofacial Surgery, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic AcidClinical Cancer Research, 2007
- Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?Bone, 2007
- Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosisAnnals of Oncology, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?Annals of Oncology, 2006